Sorafenib Completed Phase 2 Trials for Hepatocellular,Carcinoma Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01934829Urea Cream Treatment Sorafenib-Associated HSFR in HCC